This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: Steve Felstead: Innovator in CD38 Inhibition
Introduction
Steve Felstead is a notable inventor based in Earlston, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for CD38, a protein implicated in various diseases.
Latest Patents
Felstead holds a patent for "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Felstead has worked with prominent organizations such as Napa Therapeutics Limited and the Buck Institute for Research on Aging. His work in these institutions has allowed him to focus on advancing research in aging and related health issues.
Collaborations
Felstead has collaborated with esteemed colleagues, including Robert A. Volkmann and Jotham W. Coe. These partnerships have contributed to the advancement of his research and the development of effective therapeutic strategies.
Conclusion
Steve Felstead's contributions to the field of medicinal chemistry, particularly through his patent on CD38 inhibitors, highlight his role as an innovator. His work continues to influence the development of treatments for various diseases.